BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3284038)

  • 1. Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys.
    Bonneville M; Moreau JF; Blokland E; Pool J; Charron D; Goulmy E; Soulillou JP
    Transplant Proc; 1988 Apr; 20(2):193-5. PubMed ID: 3284038
    [No Abstract]   [Full Text] [Related]  

  • 2. T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones.
    Bonneville M; Moreau JF; Blokland E; Pool J; Moisan JP; Goulmy E; Soulillou JP
    J Immunol; 1988 Dec; 141(12):4187-95. PubMed ID: 3058801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human renal allograft infiltrating T cells: phenotype-function correlation and clonal heterogeneity.
    Miceli MC; Barry TS; Finn OJ
    Transplant Proc; 1988 Apr; 20(2):199-201. PubMed ID: 3284040
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune monitoring after renal transplantation. I. HLA-D expression on T cells from renal allograft recipients.
    Nowaczyk M; Górski A; Modlińska M; Rancewicz Z; Bukowska J; Ołdakowska U; Morzycka-Michalik M; Lao M
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):291-6. PubMed ID: 1667260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages and T lymphocytes expressing HLA-D region-encoded gene products in rejected renal transplants.
    Fellström B; Larsson E; Claesson K; Tufveson G; Wahlberg J; Klareskog L
    Transplant Proc; 1988 Jun; 20(3):372-4. PubMed ID: 3132767
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man.
    Tilkin AF; Michon J; Juy D; Kayibanda M; Henin Y; Sterkers G; Betuel H; Lévy JP
    J Immunol; 1987 Feb; 138(3):674-9. PubMed ID: 3492528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-D/DR identity results in a positive CML reaction.
    Buc M; Porubská S; Bencová M; Nyulassy S; Stefanovic J
    Folia Biol (Praha); 1989; 35(2):78-89. PubMed ID: 2659391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.
    Koretz K; Momburg F; Otto HF; Möller P
    Am J Pathol; 1987 Dec; 129(3):493-502. PubMed ID: 3425689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
    Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
    Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of class II antigens by subsets of activated T cells.
    Zier KS
    Cell Immunol; 1986 Jul; 100(2):525-31. PubMed ID: 3093090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells.
    Tötterman TH; Hanås E; Larsson E; Lindgren PG; Sjöberg O; Wahlberg J; Tufveson G
    Transplant Proc; 1987 Oct; 19(5):3570-1. PubMed ID: 3313860
    [No Abstract]   [Full Text] [Related]  

  • 16. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report.
    Heo WB; Kim CD; Won DI
    Transplant Proc; 2007 Dec; 39(10):3485-7. PubMed ID: 18089415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
    Berg B; Möller E
    Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HLA class II antibodies in kidney retransplant patients.
    Arnold ML; Pei R; Spriewald B; Wassmuth R
    Tissue Antigens; 2005 Apr; 65(4):370-8. PubMed ID: 15787721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
    Nunez G; McPhaul J; Stastny P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.